Toxicology of Melatonin

  title={Toxicology of Melatonin},
  author={B{\'e}atrice Guardiola‐Lema{\^i}tre},
  journal={Journal of Biological Rhythms},
  pages={697 - 706}
Despite the fact that melatonin has been released for public use in the United States by the Food and Drug Administration and is available over the counter nationwide, there currently is a total lack of information on the toxicology of melatonin. In Europe, melatonin has a completely different status in that it is considered a "neurohormone" and cannot be sold over the counter. Even though administration of melatonin in humans, as well as in animals (even at supraphysiological doses), has not… 

Figures and Tables from this paper

Safety of Melatonin in Long-Term Use(?)
  • J. Arendt
  • Medicine
    Journal of biological rhythms
  • 1997
In normal healthy adults over 18 years old, not pregnant or lactating, with no personal or family histories of psychiatric disorder, and unmedicated except for oral contraceptives and minor analgesics, the only significant short-term side effect in the author's experience has been sleepiness following oral ingestion of synthetic melatonin.
Melatonin in Wine and Beer: Beneficial Effects
The bioavailability of melatonin and resulting metabolites, the presence ofmelatonin in wine and beer and factors that influence it, and finally the different benefits related to treatment with melatonin are evaluated.
Role of melatonin on diabetes-related metabolic disorders.
Blocking the melatonin-induced inhibition of insulin secretion may be a novel therapeutic avenue for type 2 diabetes.
Melatonin. Monograph.
  • Medicine, Biology
    Alternative medicine review : a journal of clinical therapeutic
  • 2005
In patients with sleep disorders and altered circadian rhythms, oral administration of melatonin can provide the necessary resynchronization of those cycles, at dosages ranging from 0.3 to 8 mg, to illustrate the wide range of potential effects exerted by melatonin.
Melatonin: Countering Chaotic Time Cues
The present text will consider the physiological role of endogenous melatonin, and the mostly pharmacological effects of exogenous treatment, on the assumption that normal circulating concentrations represent endogenous pineal production.
Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin
Research in the next decade will help to define the role of melatonin in age-related diseases and in determining successful aging, and improving health and the quality of life in the aged should be an aim of this research.
Role of the Melatonin System in the Control of Sleep
The hypnotic and rhythm-regulating properties of melatonin and its agonists make them an important addition to the armamentarium of drugs for treating primary and secondary insomnia and circadian rhythm sleep disorders.
REVIEW: Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance
  • G. Bubenik
  • Medicine, Biology
    Digestive Diseases and Sciences
  • 2004
Because of its unique properties, melatonin could be considered for prevention or treatment of colorectal cancer, ulcerative colitis, gastric ulcers, irritable bowel syndrome, and childhood colic.
Therapeutic potential of melatonin receptor agonists and antagonists
The efficacy and effectiveness of melatonin receptor agonists should be greatly increased and the side-effects reduced by targeting receptor subtypes mediating specific functions, and the current need for the synthesis and characterisation of high affinity and subtype-selectivemelatonin receptor antagonists to further elucidate the physiological role ofmelatonin is discussed.


Pharmacology and function of melatonin receptors
  • M. Dubocovich
  • Biology, Chemistry
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 1988
Recent advances in the pharmacological characterization of melatonin receptors in the central nervous system will further stimulate the search for potent and selective melatonin receptor agonists and antagonists, and should aid in the understanding of the mechanism of action ofmelatonin in mammalian brain.
Antioxidant actions of melatonin.
Structure-activity studies of melatonin analogues in prepubertal male rats.
Although the hypothesis that melatonin acts as a prohormone and that the ring schism metabolites (kynurenamines) mediate many of the effects attributable to melatonin could not be confirmed, modification of the melatonin structure by lengthening the acrylamide side chain or by replacing the 5 methoxy function with fluorine resulted in loss of biological potency.
Melatonin potentially useful but safety, efficacy remain uncertain.
Until solid evidence is in, physicians should prescribe pharmacological and behavioral treatments of known value for sleep disorders, caution patients against the chronic use of melatonin, and monitor those who do take it.
Bioavailability of oral melatonin in humans.
The area under the concentration-time curve for serum melatonin correlated well with the cumulative melatonin excretion during the initial 15 h after melatonin's administration, indicating that either approach can be used to estimate the absorption of orally administered melatonin.
Melatonin and the immune-hematopoietic system therapeutic and adverse pharmacological correlates.
Melatonin seems to be an important immunomodulatory hormone which deserves to be further studied to identify its relevance in immune-based diseases, its therapeutic indications and its adverse effects.
The pineal and its hormones in the control of reproduction in mammals.
By the usual criteria in endocrinology, the pineal now fulfills all the qualifications of an organ of internal secretion.
Dopamine Inhibits Melatonin Synthesis in Photoreceptor Cells Through a D2‐Like Receptor Subtype in the Rat Retina: Biochemical and Histochemical Evidence
Results support the control of melatonin levels by dopamine through a D2C/D4 receptor in photoreceptor cells of the rat retina through an intrinsic oscillator, using dopamine and melatonin as antagonist signals.
Melatonin Administration to Blind People: Phase Advances and Entrainment
The purpose of this study was to test the phase-shifting and entraining effects of melatonin in human subjects, and found five totally blind men found to have free-running endogenous melatonin rhythms to be remarkably stable.
Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor.
The Mel1b melatonin receptor may mediate the reported actions of melatonin in retina and participate in some of the neurobiological effects ofmelatonin in mammals.